In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Antiplatelet Agents (Expert Consensus Document on the Use of)

ESC Clinical Practice Guidelines

Acute Coronary Syndromes (ACS)
Cardiovascular Pharmacology and Pharmacotherapy
Guidelines version available to download
Published in 2004
Reference European Heart Journal (2004) 25, 166–181; doi:10.1016/j.ehj.2003.10.013
Published in 2004
Reference APLT
PDA
Published in 2004
Reference Download the PDA version
Table of contents: Full Text (ESC Clinical Practice Guidelines)
  1. Preamble
  2. Introduction
  3. Platelet pathophysiology
  4. Mechanism of action and clinical efficacy of antiplatelet drugs
  5. Drugs inducing a reversible inhibition of platelet function
  6. Patients that may benefit from antiplatelet therapy
  7. Balance of benefits and risks of antiplatelet therapy
  8. Recommendations concerning individual antiplatelet agents
  9. Areas where we need new trials
  10. Conclusion
  11. Summary
  12. References

 

 

 

Back to top